Anabolic precursor | Total demand (µmol g −1CDW ) |  | Uptake (%)a | De novo biosynthesis (%) | Resulting de novo demand (µmol g −1CDW ) |
---|---|---|---|---|---|
G6P | 604.8 |
| 12.5 ± 0.4 | 87.5 ± 0.4 | 529.2 ± 2.7 |
F6Pb | 821.0 |
| 0.0 | 100.0 | 821.0 |
R5Pb | 329.9 |
| 94.8 | 5.2 | 17.3 |
E4P | 238.8 |
| 98.0 ± 2.9 | 2.0 ± 3.4 | 4.8 ± 7.2 |
G3Pb | 240.4 |
| 0.0 | 100.0 | 240.4 |
3PG | 707.4 |
| 94.8 ± 5.1 | 5.2 ± 5.0 | 37.1 ± 36.0 |
PEP | 449.6 |
| 97.9 ± 2.9 | 2.1 ± 2.7 | 9.6 ± 14.3 |
PYR | 1783.1 |
| 96.0 ± 1.0 | 4.0 ± 1.0 | 71.5 ± 14.9 |
AcCoA | 6572.7 | Â | n.d. | n.d. | n.d. |
OAA | 1124.5 |
| 88.5 ± 1.9 | 11.5 ± 1.9 | 129.8 ± 20.5 |
AKG | 800.4 |
| 60.8 ± 1.5 | 39.2 ± 1.5 | 313.7 ± 10.7 |
NADPH | 10,659.9 |
| 93.3 ± 0.1 | 6.7 ± 0.2 | 721.1 ± 62.3 |